Bajaj Auto and Sun Pharmaceuticals will be some of the other stocks to watch before going into trade on Monday.

After a record FY25, the drugmaker sees new growth engines in biologics, vaccines, and devices powering expansion in FY26.

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Zydus Lifesciences Q4 stuns with margin guidance, but brokerages trim targets — stock ends at Rs 890. Should you follow ...

Zydus Lifesciences has received final approval from the USFDA to launch its isotretinoin capsules USP in six different ...

The approved medication is a generic version of Absorica and is indicated for the treatment of severe, disfiguring nodular ...

Zydus Lifesciences is innovating a single-device for semaglutide. This device can deliver multiple strengths of the drug. It ...

Zydus Lifesciences consolidated net profit slipped about 1 per cent year-on-year (Y-o-Y) to ₹1,171 crore in the March quarter ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Zydus ...

Zydus Wellness unveils new brand identity, reports strong financial growth, and focuses on science-backed innovation and ...

Apart from earnings, Zydus Wellness has also announced a stock split and dividend. The board has approved the stock split in ...

The pharma companys Board has recommended a final dividend of Rs 11 per equity share of face value Rs 1 each, representing a ...